Skip to main content
. Author manuscript; available in PMC: 2017 Sep 15.
Published in final edited form as: Clin Cancer Res. 2016 Apr 1;22(18):4643–4650. doi: 10.1158/1078-0432.CCR-15-2785

Figure 5. PTK2/FAK copy number is associated with disease recurrence in HPV-negative HNSCC.

Figure 5

PTK2/FAK copy number is associated with poorer disease-free survival (DFS) in an inpatients with HNSCC treated with radiotherapy at MD Anderson, considered both separately (A and B) and combined (C). PTK2/FAK copy number trends to association with DFS in the Head and Neck Cancer TCGA cohort as well (P=0.063).